ROFERON (RIFN-ALPHA(2A)) IS MORE IMMUNOGENIC THAN INTRON-A (RIFN-ALPHA(2B)) IN PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA

Erstveröffentlichung
1994Authors
Vonwussow, P
Hehlmann, R
Hochhaus, T
Jakschies, D
Nolte, KU
Beitrag zu einer Konferenz
Published in
Journal of interferon research ; 14 (1994), 4. - S. 217-219. - ISSN 0197-8357
Link to publication
https://dx.doi.org/10.1089/jir.1994.14.217Institutions
UKU. Klinik für Innere Medizin IIIConference
1994 European Interferon Workshop on Antagonists and Antibodies to Interferons and Other Therapeutically Used Human Proteins, 1994-02-16 - 1994-02-18, Hannover, Germany
Subject headings
[Free subject headings]: interferon-alpha therapy | recombinant | antibodies[DDC subject group]: DDC 610 / Medicine & health